HuMax-CD4: Phase I/II

GEN reported that in an open label study, 10 RA patients given a

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE